Bluefin Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-14,462
| Closed | -$842K | – | 372 |
|
|
2021
Q4 | $842K | Buy |
14,462
+462
| +3% | +$26.9K | 0.06% | 209 |
|
|
2021
Q3 | $841K | Sell |
14,000
-2,524
| -15% | -$152K | 0.08% | 152 |
|
|
2021
Q2 | $990K | Sell |
16,524
-1,376
| -8% | -$82.4K | 0.06% | 160 |
|
|
2021
Q1 | $890K | Buy |
+17,900
| New | +$890K | 0.04% | 174 |
|
|
2020
Q4 | – | Hold |
0
| – | -$510K | – | 424 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 146 |
|
|
2019
Q1 | – | Sell |
-8,900
| Closed | -$338K | – | 206 |
|
|
2018
Q4 | $338K | Sell |
8,900
-500
| -5% | -$19K | 0.03% | 136 |
|
|
2018
Q3 | $372K | Buy |
9,400
+2,700
| +40% | +$107K | 0.03% | 203 |
|
|
2018
Q2 | $235K | Buy |
6,700
+300
| +5% | +$10.5K | 0.02% | 204 |
|
|
2018
Q1 | $224K | Buy |
6,400
+100
| +2% | +$3.5K | 0.02% | 192 |
|
|
2017
Q4 | $219K | Hold |
6,300
| – | – | 0.01% | 270 |
|
|
2017
Q3 | $213K | Buy |
+6,300
| New | +$213K | 0.03% | 261 |
|
|
2017
Q1 | – | Sell |
-9,800
| Closed | -$268K | – | 270 |
|
|
2016
Q4 | $268K | Buy |
+9,800
| New | +$268K | 0.02% | 238 |
|
|
2016
Q3 | – | Sell |
-39,938
| Closed | -$1.21M | – | 230 |
|
|
2016
Q2 | $1.21M | Buy |
+39,938
| New | +$1.21M | 0.12% | 105 |
|
|
2015
Q1 | – | Sell |
-15,144
| Closed | -$533K | – | 314 |
|
|
2014
Q4 | $533K | Sell |
15,144
-867,122
| -98% | -$30.5M | 0.03% | 255 |
|
|
2014
Q3 | $31.5M | Buy |
882,266
+221,760
| +34% | +$7.92M | 1.73% | 6 |
|
|
2014
Q2 | $24.5M | Buy |
660,506
+647,016
| +4,796% | +$24M | 1.05% | 7 |
|
|
2014
Q1 | $400K | Buy |
+13,490
| New | +$400K | 0.03% | 288 |
|